vs

Side-by-side financial comparison of Advantage Solutions Inc. (ADV) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

Advantage Solutions Inc. is the larger business by last-quarter revenue ($932.1M vs $487.7M, roughly 1.9× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -17.4%, a 7.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 4.5%). Advantage Solutions Inc. produced more free cash flow last quarter ($23.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 4.0%).

LexisNexis Risk Solutions is a global data and analytics company that provides data and technology services, analytics, predictive insights, and fraud prevention for a wide range of industries. It is headquartered in Alpharetta, Georgia, and has offices throughout the U.S. and in Australia, Brazil, China, France, Hong Kong, India, Ireland, Israel, the Philippines, and the United Kingdom.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

ADV vs CLOV — Head-to-Head

Bigger by revenue
ADV
ADV
1.9× larger
ADV
$932.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+40.3% gap
CLOV
44.7%
4.5%
ADV
Higher net margin
CLOV
CLOV
7.2% more per $
CLOV
-10.1%
-17.4%
ADV
More free cash flow
ADV
ADV
$92.4M more FCF
ADV
$23.4M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
4.0%
ADV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADV
ADV
CLOV
CLOV
Revenue
$932.1M
$487.7M
Net Profit
$-161.7M
$-49.3M
Gross Margin
Operating Margin
-17.4%
-10.1%
Net Margin
-17.4%
-10.1%
Revenue YoY
4.5%
44.7%
Net Profit YoY
9.2%
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADV
ADV
CLOV
CLOV
Q4 25
$932.1M
$487.7M
Q3 25
$915.0M
$496.6M
Q2 25
$873.7M
$477.6M
Q1 25
$821.8M
$462.3M
Q4 24
$892.3M
$337.0M
Q3 24
$939.3M
$331.0M
Q2 24
$873.4M
$356.3M
Q1 24
$861.4M
$346.9M
Net Profit
ADV
ADV
CLOV
CLOV
Q4 25
$-161.7M
$-49.3M
Q3 25
$20.6M
$-24.4M
Q2 25
$-30.4M
$-10.6M
Q1 25
$-56.1M
$-1.3M
Q4 24
$-178.0M
$-22.1M
Q3 24
$-42.8M
$-9.2M
Q2 24
$-100.8M
$7.4M
Q1 24
$-5.3M
$-19.2M
Gross Margin
ADV
ADV
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
ADV
ADV
CLOV
CLOV
Q4 25
-17.4%
-10.1%
Q3 25
4.4%
-4.9%
Q2 25
1.1%
-2.2%
Q1 25
-1.8%
-0.3%
Q4 24
-19.1%
-6.4%
Q3 24
-0.3%
-2.7%
Q2 24
-10.4%
2.0%
Q1 24
-3.5%
-6.5%
Net Margin
ADV
ADV
CLOV
CLOV
Q4 25
-17.4%
-10.1%
Q3 25
2.2%
-4.9%
Q2 25
-3.5%
-2.2%
Q1 25
-6.8%
-0.3%
Q4 24
-20.0%
-6.6%
Q3 24
-4.6%
-2.8%
Q2 24
-11.5%
2.1%
Q1 24
-0.6%
-5.5%
EPS (diluted)
ADV
ADV
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-0.13
Q2 24
$-0.31
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADV
ADV
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$240.8M
$78.3M
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$554.0M
$308.7M
Total Assets
$2.8B
$541.0M
Debt / EquityLower = less leverage
3.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADV
ADV
CLOV
CLOV
Q4 25
$240.8M
$78.3M
Q3 25
$201.1M
Q2 25
$102.9M
Q1 25
$121.1M
Q4 24
$205.2M
$194.5M
Q3 24
$196.1M
$288.0M
Q2 24
$154.0M
$254.8M
Q1 24
$112.3M
$208.3M
Total Debt
ADV
ADV
CLOV
CLOV
Q4 25
$1.7B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ADV
ADV
CLOV
CLOV
Q4 25
$554.0M
$308.7M
Q3 25
$708.5M
$340.9M
Q2 25
$683.6M
$344.2M
Q1 25
$695.6M
$336.1M
Q4 24
$748.7M
$341.1M
Q3 24
$932.5M
$342.2M
Q2 24
$973.7M
$324.9M
Q1 24
$1.1B
$292.5M
Total Assets
ADV
ADV
CLOV
CLOV
Q4 25
$2.8B
$541.0M
Q3 25
$3.0B
$559.7M
Q2 25
$3.0B
$575.0M
Q1 25
$3.0B
$583.7M
Q4 24
$3.1B
$580.7M
Q3 24
$3.4B
$653.0M
Q2 24
$3.5B
$674.2M
Q1 24
$3.6B
$671.8M
Debt / Equity
ADV
ADV
CLOV
CLOV
Q4 25
3.05×
Q3 25
Q2 25
Q1 25
Q4 24
2.30×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADV
ADV
CLOV
CLOV
Operating Cash FlowLast quarter
$45.6M
$-66.9M
Free Cash FlowOCF − Capex
$23.4M
$-69.0M
FCF MarginFCF / Revenue
2.5%
-14.1%
Capex IntensityCapex / Revenue
2.4%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$10.7M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADV
ADV
CLOV
CLOV
Q4 25
$45.6M
$-66.9M
Q3 25
$63.6M
$12.1M
Q2 25
$-8.1M
$5.4M
Q1 25
$-39.6M
$-16.3M
Q4 24
$15.1M
$34.8M
Q3 24
$34.0M
$50.0M
Q2 24
$53.4M
$44.8M
Q1 24
$-9.4M
$25.9M
Free Cash Flow
ADV
ADV
CLOV
CLOV
Q4 25
$23.4M
$-69.0M
Q3 25
$52.2M
$11.4M
Q2 25
$-10.2M
$4.8M
Q1 25
$-54.7M
$-16.5M
Q4 24
$-27.4M
$33.3M
Q3 24
$8.6M
$49.6M
Q2 24
$43.8M
$44.4M
Q1 24
$-24.8M
$25.5M
FCF Margin
ADV
ADV
CLOV
CLOV
Q4 25
2.5%
-14.1%
Q3 25
5.7%
2.3%
Q2 25
-1.2%
1.0%
Q1 25
-6.7%
-3.6%
Q4 24
-3.1%
9.9%
Q3 24
0.9%
15.0%
Q2 24
5.0%
12.5%
Q1 24
-2.9%
7.3%
Capex Intensity
ADV
ADV
CLOV
CLOV
Q4 25
2.4%
0.4%
Q3 25
1.3%
0.1%
Q2 25
0.2%
0.1%
Q1 25
1.8%
0.0%
Q4 24
4.8%
0.5%
Q3 24
2.7%
0.1%
Q2 24
1.1%
0.1%
Q1 24
1.8%
0.1%
Cash Conversion
ADV
ADV
CLOV
CLOV
Q4 25
Q3 25
3.09×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADV
ADV

Experiential Services$395.9M42%
Branded Services$289.8M31%
Retailer Services$246.5M26%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons